Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Penumbra, Inc. Common Stock (NY: PEN )

291.68 -11.44 (-3.77%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 635,329
Open 303.00
Bid (Size) 284.71 (1)
Ask (Size) 305.21 (1)
Prev. Close 303.12
Today's Range 290.55 - 304.11
52wk Range 148.00 - 310.00
Shares Outstanding 36,580,540
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stroke Device Maker Penumbra Stock Surges On Earnings Beat, Analysts Boost Price Forecasts After Upbeat 2025 Outlook
Penumbra stock climbs after Q4 earnings surpass expectations, with sales up 10.8% Y/Y. Analysts raise price targets as the company projects strong 2025 growth. 
Via Benzinga
Topics Earnings
Exposures Financial
Why Penumbra (PEN) Stock Is Trading Up Today
Shares of medical device company Penumbra (NYSE:PEN) jumped 13.6% in the afternoon session after the company reported impressive fourth-quarter 2024 results, which blew past analysts' constant currency... 
Via StockStory

Performance

YTD
+21.54%
+21.54%
1 Month
+6.54%
+6.54%
3 Month
+19.21%
+19.21%
6 Month
+44.35%
+44.35%
1 Year
+22.36%
+22.36%

More News

Read More
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
10 Analysts Assess Penumbra: What You Need To Know
Via Benzinga
Peering Into Penumbra's Recent Short Interest
Via Benzinga
(PEN) - Analyzing Penumbra's Short Interest
Via Benzinga
Profit Machine Penumbra Surges On Solid Fourth-Quarter Beat, But Guidance Lags
Via Investor's Business Daily
Penumbra’s (NYSE:PEN) Q4 Sales Beat Estimates
Via StockStory
Topics Earnings
Exposures Financial
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Via StockStory
Price Over Earnings Overview: Penumbra
Via Benzinga
12 Analysts Assess Penumbra: What You Need To Know
Via Benzinga
(PEN) - Analyzing Penumbra's Short Interest
Via Benzinga
Breaking Down Penumbra: 11 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For February 18, 2025
Via Benzinga
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
Via StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
Via StockStory
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Inspire Medical's Sleep Innovations Driving Big Gains
Via Investor's Business Daily
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Inari Medical Catapults 30% On Rumored Stryker Takeover
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Via Benzinga
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.